Original-Research

Bittium Oyj (von NuWays AG): BUY 20.02.2026, 09:00 Uhr von dpa-AFX Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
Bittium Corporation 39,58 EUR +2,66 % Baader Bank

^

Original-Research: Bittium Oyj - from NuWays AG

20.02.2026 / 09:00 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to Bittium Oyj

Company Name: Bittium Oyj

ISIN: FI0009007264

Reason for the research: Update

Recommendation: BUY

Target price: EUR 40

Target price on sight of: 12 months

Last rating change:

Analyst: Julius Neittamo

Outstanding Q4 as expected, cautious FY26 guidance

Yesterday, Bittium reported record results and presented its financial

guidance for FY26. The report was known to be very strong, as the company

had recently raised its FY25 outlook. Group results beat many of our

estimates, with a very strong Defense & Security segment, while Medical and

Engineering Services disappointed. Guidance for FY26 is EUR 140-155m for net

sales and EUR 26-32m for operating profit, broadly in line with our previous

estimates. Yet, this remains a cautious guidance, that can be beat thanks to

positive momentum. Our review in detail:

Q4'25 with outstanding Defense & Security performance: Group net sales grew

62.5% yoy to EUR 53.9m (beat eNuW +52.9%/EUR 50.3m), achieving the highest

quarterly revenue in Bittium's history, supported by several new orders in

Defence & Security. EBIT came in at EUR 15.4m (beat eNuW EUR 15m), while EBIT

margin was 28.5% (vs eNuW 29.8%). Management used its discretion to

accelerate depreciation of Tough SDR technology following the Indra

licensing deal (depreciation EUR 7.6m in Q4 vs EUR 2.6m year prior).

Medical and Engineering Services (17% of group sales in Q4) dragged

operating margins, both achieving EBIT EUR -0.1m (vs eNuW EUR +0.6m/EUR +0.3m

respectively).

Q4 new orders reached a record EUR97.9m, +152 yoy (FY25 orders jumped by 50%

to EUR 153m), mainly driven by Defence deals: (i) Finnish Defence Forces

EUR15.9m (Tough SDR radios), (ii) Austria EUR18.5m (TAC WIN systems) and, (iii)

Indra EUR 50m licensing deal.

The board has proposed a EUR 0.15/sh. dividend on FY-25 results (0.10/sh. last

year) and an extraordinary dividend of EUR 0.15/sh.

FY26 guidance was broadly in line at the midpoint, implying 17-30% sales

growth to EUR 140-155m and 34-65% EBIT growth to EUR 26-32m. FY26 Outlook is

well supported by a robust backlog of EUR 77.9m at the end of 2025 (vs. EUR45.1m

year earlier). The sales guidance is cautious, given that the company is

currently in talks with ~10 different militaries, while targets to win at

least one "decent sized country" as customer this year. With the ongoing

commercial momentum and newsflow, the guidance can be beat. Note that the

recent success with Indra positions Bittium as a legitimate partner for the

larger European militaries, increasing expectations for key auctions in

2026, notably the upcoming tender for renewing tactical communication

systems for the British Armed Forces.

We make a few adjustments to the DCF model: Our FY26 net sales is slightly

increased and lands at EUR 154m (+29% yoy), on the upper end of the guidance,

to reflect a higher contribution from Indra. In FY26, EBIT is reduced from EUR

30.8m (20.7% margin) to EUR 27.6m (18% margin) due to the aforementioned

higher depreciation driven by the Indra licensing deal. New estimates

results in an unchanged PT, due to higher working capital needs. We

reiterate our BUY rating on continued momentum.

You can download the research here:

https://eqs-cockpit.com/c/fncls.ssp?u=6e138e8283f165fdd37a081458371147

For additional information visit our website:

https://www.nuways-ag.com/research-feed

Contact for questions:

NuWays AG - Equity Research

Web: www.nuways-ag.com

Email: research@nuways-ag.com

LinkedIn: https://www.linkedin.com/company/nuwaysag

Adresse: Mittelweg 16-17, 20148 Hamburg, Germany

++++++++++

Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss

bestimmter Börsengeschäfte.

Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben

analysierten Unternehmen befindet sich in der vollständigen Analyse.

++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

View original content:

https://eqs-news.com/?origin_id=da7b6958-0e2f-11f1-8534-027f3c38b923&lang=en

---------------------------------------------------------------------------

2279052 20.02.2026 CET/CEST

°

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer